By InvitationNot Applicable

Cognitive Rehabilitation and Exposure Therapy for Geriatric Hoarding

United States150 participantsStarted 2022-11-21

Plain-language summary

Hoarding disorder (HD) is a chronic, progressive, and debilitating psychiatric condition that leads to devastating personal and public consequences, particularly for older adults. This confirmatory efficacy trial will advance our knowledge of the mechanisms of action in the treatment of HD as well as reduce symptom severity, disability, and community consequences.

Who can participate

Age range50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * adults age 50 and older * voluntary informed consent for participation * DSM-5 diagnosis of HD * HD as a primary, most severe diagnosis * stable on medications for at least 8 weeks Exclusion Criteria: * current psychosis or mania as measured by the Mini-International * current or history of any neurodegenerative disease * substance use disorder * current use of benzodiazepine medication * suicidality * current participation in exposure-based therapy

What they're measuring

Change in Saving Inventory-Revised (SI-R)

Timeframe: through study completion, an average of 1 year

Change in Self-report Clutter Image Rating (CIR)

Timeframe: through study completion, an average of 1 year

Trial details

NCT IDNCT05254015

SponsorUniversity of California, San Diego

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-02-28

View on ClinicalTrials.gov More Hoarding Disorder trials